One advantage of conducting an online scientific conference is that more individuals will gain access to information presented at the meeting, said Robert Gabbay, MD, PhD, the newly appointed chief medical and scientific officer of the American Diabetes Association.
One advantage of conducting an online scientific conference is that more individuals will gain access to information presented at the meeting, said Robert Gabbay, MD, PhD, the newly appointed chief medical and scientific officer of the American Diabetes Association.
Transcript:
As the new chief scientific and medical officer at the American Diabetes Association (ADA), what are your goals for the organization?
It is the most comprehensive organization focused on improving the lives of people with diabetes and serving the professional community around diabetes. I look to continue to foster that wonderful work and really ensure that it has greater impact on all of our constituents.
This is the 80th Scientific Sessions hosted by the ADA, but the first one to be conducted virtually. What are you looking forward to?
I think it's an exciting time. Obviously, we've been challenged by coronavirus disease 2019 (COVID-19) to have to pivot to do this virtually. But what we hope is one of the advantages of doing it virtually, is that we can have more people have access to the amazing information that occurs at this meeting. Some years people can't travel to whatever the location is. Now, we can all do this from the comfort of our office or home. I hope that we have even greater participation as a result. Because we are capturing all of the sessions on video, we have the opportunity then to have this as enduring material that can be distributed again, all over the world.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Need for Pharmacogenomic Testing in Mental Health Care Explored at AMCP 2024
April 17th 2024Presenters from Mayo Clinic discussed the benefits of implementing pharmacogenomic testing in mental health care for the betterment of patient outcomes, reducing medical costs, and more at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting.
Read More